Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,075 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01872988 | Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma | terminated | Phase 3 | 320 | Taichung Veterans General HospitalOTHER | 1 | Sep 4, 2014 | clinicaltrials |
| NCT01214720 | A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | completed | Phase 3 | 607 | Hoffmann-La RocheINDUSTRY | 21 | Aug 13, 2014 | clinicaltrials |
| NCT00678535 | Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer(EXPAND) | completed | Phase 3 | 904 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 25 | Jul 21, 2014 | clinicaltrials |
| NCT00113607 | An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer | completed | Phase 3 | 672 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 20 | Jun 27, 2014 | clinicaltrials |
| NCT00148798 | Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)(FLEX) | completed | Phase 3 | 1,861 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 28 | Jun 25, 2014 | clinicaltrials |
| NCT01142479 | Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy | completed | Phase 2 / Phase 3 | 60 | Taipei City HospitalOTHER_GOV | 1 | May 29, 2014 | clinicaltrials |
| NCT00242567 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | completed | Phase 3 | 522 | Novartis PharmaceuticalsINDUSTRY | 10 | May 7, 2014 | clinicaltrials |
| NCT00492752 | A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 3 | 226 | BayerINDUSTRY | 3 | Apr 16, 2014 | clinicaltrials |
| NCT00586105 | Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC) | completed | Phase 3 | 39 | BayerINDUSTRY | 2 | Apr 16, 2014 | clinicaltrials |
| NCT02074202 | To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma | unknown | Phase 3 | 150 | National Taiwan University HospitalOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | unknown | Phase 2 / Phase 3 | 300 | Taichung Veterans General HospitalOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT00312208 | Docetaxel in Breast Cancer | completed | Phase 3 | 3,299 | SanofiINDUSTRY | 37 | Dec 30, 2013 | clinicaltrials |
| NCT00262067 | A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) | unknown | Phase 3 | 1,237 | Genentech, Inc.INDUSTRY | 22 | Dec 13, 2013 | clinicaltrials |
| NCT00322452 | First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia(IPASS) | completed | Phase 3 | 1,329 | AstraZenecaINDUSTRY | 9 | Nov 7, 2013 | clinicaltrials |
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
| NCT00041275 | Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 300 | National Medical Research Council (NMRC), SingaporeOTHER_GOV | 10 | Sep 20, 2013 | clinicaltrials |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 34 | Aug 21, 2013 | clinicaltrials |
| NCT00673049 | Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer(NSCLC) | terminated | Phase 3 | 583 | PfizerINDUSTRY | 27 | Jul 24, 2013 | clinicaltrials |
| NCT00486954 | Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer | completed | Phase 3 | 273 | GlaxoSmithKlineINDUSTRY | 4 | Jun 20, 2013 | clinicaltrials |
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT00049998 | Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 31 | Mar 4, 2013 | clinicaltrials |
| NCT01802021 | Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients(QSYQT) | unknown | Phase 2 / Phase 3 | 120 | Chang Gung Memorial HospitalOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT00411229 | Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer(CLASSIC) | completed | Phase 3 | 1,035 | SanofiINDUSTRY | 3 | Feb 20, 2013 | clinicaltrials |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy(SAVE-ONCO) | completed | Phase 3 | 3,212 | SanofiINDUSTRY | 49 | Jan 23, 2013 | clinicaltrials |
| NCT00699374 | Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer | terminated | Phase 3 | 1,075 | PfizerINDUSTRY | 23 | Jan 14, 2013 | clinicaltrials |
| NCT00610636 | Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy | unknown | Phase 3 | 200 | National Taiwan University HospitalOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00360841 | Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting | completed | Phase 3 | 103 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00601549 | A Randomized Controlled Clinical Trial Comparing Oncological Results and Functional Recovery Between Laparoscopic and Open Method for the Treatment of Advanced Rectal Cancer After Concurrent Chemoradiation Therapy (CCRT) | unknown | Phase 3 | 600 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT01727635 | The Long-term Effects of Body-mind-spirit Group Therapy | completed | Phase 2 / Phase 3 | 60 | National Taiwan University HospitalOTHER | 1 | Nov 16, 2012 | clinicaltrials |
| NCT01398657 | Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer | unknown | Phase 3 | 182 | National Taiwan University HospitalOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT00498225 | Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer(GEST) | completed | Phase 3 | 834 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 2 | Nov 2, 2012 | clinicaltrials |
| NCT00065468 | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma(ARCC) | completed | Phase 3 | 626 | PfizerINDUSTRY | 25 | Oct 25, 2012 | clinicaltrials |
| NCT00316706 | Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine | completed | Phase 3 | 1,245 | GlaxoSmithKlineINDUSTRY | 5 | Sep 18, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT01009593 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 3 | 1,035 | AbbottINDUSTRY | 29 | Sep 10, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00707304 | Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer(FORTIS-M) | completed | Phase 3 | 742 | AgennixINDUSTRY | 23 | Aug 21, 2012 | clinicaltrials |
| NCT00471146 | Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | completed | Phase 3 | 630 | PfizerINDUSTRY | 24 | Jul 16, 2012 | clinicaltrials |
| NCT00002777 | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 342 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Jul 2, 2012 | clinicaltrials |
| NCT00373113 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | terminated | Phase 3 | 482 | PfizerINDUSTRY | 23 | Jun 25, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00414024 | Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. | terminated | Phase 3 | 11 | NovartisINDUSTRY | 6 | Apr 20, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00225290 | Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve | terminated | Phase 3 | 230 | TTY BiopharmINDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00520676 | Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 3 | 260 | Eli Lilly and CompanyINDUSTRY | 6 | Aug 10, 2011 | clinicaltrials |
| NCT00415194 | A Study for Patients With Head and Neck Cancer | completed | Phase 3 | 795 | Eli Lilly and CompanyINDUSTRY | 21 | Jun 28, 2011 | clinicaltrials |
| NCT00568308 | Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma(PATHWAY) | terminated | Phase 3 | 600 | Progen PharmaceuticalsINDUSTRY | 10 | Jun 15, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials